Latanoprost Bgr

Latanoprost, the active ingredient in Latanoprost Bgr, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function and slow disease progression.

GNH USA supplies Latanoprost Bgr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides full regulatory documentation for global distribution.

Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intra‑ocular pressure.

- Open‑angle glaucoma: reduces intra‑ocular pressure, slowing optic nerve damage. - Ocular hypertension: lowers eye pressure to prevent progression to glaucoma. - Elevated intra‑ocular pressure: helps maintain normal pressure levels and protect visual fields.

Latanoprost may cause a range of ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of eye color. - Eye irritation: burning or stinging sensation. - Blurred vision: temporary visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Ocular inflammation: uveitis or iritis. - Paradoxical IOP increase: unexpected rise in pressure. - Corneal edema: swelling of the cornea affecting clarity. - Vision loss: sudden decrease in visual acuity. - Ocular infection: signs of bacterial or fungal infection.

Before initiating therapy, clinicians should evaluate ocular health and monitor response.

- Baseline IOP assessment: record intra‑ocular pressure prior to use. - Follow‑up monitoring: re‑measure IOP after starting treatment. - Active eye infection: avoid use until infection resolves. - History of uveitis: use with caution and monitor closely. - Concomitant prostaglandin analogs: avoid simultaneous use to prevent additive effects. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Other prostaglandin analog eye drops: additive IOP‑lowering may cause hypotony. - Cholinergic agents (e.g., pilocarpine): may reduce Latanoprost efficacy. - Topical ocular steroids: can counteract pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: potential additive IOP reduction. - Systemic antihypertensives: monitor blood pressure for unexpected changes. - Contact lens wear: may affect drug absorption and comfort.